Abstract

Thoracic aortic aneurysm is a pathological local dilatation of the aorta, potentially leading to aortic rupture or dissection. The disease is a common complication of patients with bicuspid aortic valve, a congenital disorder present in 1-2% of the population. Using two dimensional fluorescence difference gel electrophoresis proteomics followed by mRNA expression, and alternative splicing analysis of the identified proteins, differences in dilated and nondilated aorta tissues between 44 patients with bicuspid and tricuspid valves was examined. The pattern of protein expression was successfully validated with LC-MS/MS. A multivariate analysis of protein expression data revealed diverging protein expression fingerprints in patients with tricuspid compared with the patients with bicuspid aortic valves. From 302 protein spots included in the analysis, 69 and 38 spots were differentially expressed between dilated and nondilated aorta specifically in patients with tricuspid and bicuspid aortic valve, respectively. 92 protein spots were differentially expressed between dilated and nondilated aorta in both phenotypes. Similarly, mRNA expression together with alternative splicing analysis of the identified proteins also showed diverging fingerprints in the two patient groups. Differential splicing was abundant but the expression levels of differentially spliced mRNA transcripts were low compared with the wild type transcript and there was no correlation between splicing and the number of spots. Therefore, the different spots are likely to represent post-translational modifications. The identification of differentially expressed proteins suggests that dilatation in patients with a tricuspid aortic valve involves inflammatory processes whereas aortic aneurysm in patients with BAV may be the consequence of impaired repair capacity. The results imply that aortic aneurysm formation in patients with bicuspid and tricuspid aortic valves involve different biological pathways leading to the same phenotype.

Highlights

  • From the ‡Atherosclerosis Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; §Inserm U744, Institut Pasteur de Lille, University of Lille Nord de France, Lille, France; ¶Clinical Proteomics Mass Spectrometry, Department of Oncology-Pathology, Science for Life Laboratory and Karolinska Institutet, Stockholm, Sweden; ʈCardiothoracic Surgery Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

  • Previous studies on molecular mechanisms in Thoracic aortic aneurysm (TAA) have shown that patients with tricuspid aortic valve (TAV) have diverging mRNA expression profiles compared with patients with bicuspid aortic valve (BAV) [2, 3] as well as diverging alternative splicing fingerprints in the transforming growth factor-beta signaling pathway [4]

  • Our results collectively demonstrated that TAA formation in patients with BAV has clearly diverging expression fingerprints compared with the patients with TAV, at all three levels of gene, exon and protein analysis

Read more

Summary

EXPERIMENTAL PROCEDURES

Clinical Samples—Aortic biopsies were obtained through the Advanced Study of Aortic Pathology (ASAP) [5]. MRNA Expression Level Statistical Data Analysis—In the present study, PCA [7] was applied to meta probe set (gene) expression data for 43 unique genes that were identified by protein expression analysis and 81 patients including 51 dilated (15 TAV, 36 BAV) and 30 nondilated (14 TAV, 16 BAV) previously published thoracic aorta intima/media samples [4]. Both PCA and OPLS-DA were applied to this data set. Immunohistochemistry—Immunohistochemistry was performed on paraffin embedded sections taken from aorta of dilated and nondilated patients, stained with anti-human TTR (SC-13098), VIM (SC66002), LDH (SC-33781), TGM2 (SC-20621), all purchased from Santa Cruz Biotechnology

RESULTS
DISCUSSION
No of protein spotsd
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call